Clover Health Investments, Corp.
Clover Health Investments, Corp. (CLOV) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Clover Health Investments, Corp. (CLOV), featuring income statements, balance sheets, and cash flow data.
Clover Health Investments, Corp. (CLOV) Income Statement & Financial Overview
Review Clover Health Investments, Corp. CLOV income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $462.33M | $336.96M | $330.99M | $356.26M |
| Cost of Revenue | $353.44M | $243.04M | $249.77M | $248.35M |
| Gross Profit | $108.89M | $93.92M | $81.21M | $107.91M |
| Gross Profit Ratio | $0.24 | $0.28 | $0.25 | $0.30 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $109.70M | $115.02M | $90.20M | $99.92M |
| Operating Expenses | $110.16M | $115.37M | $90.00M | $100.73M |
| Total Costs & Expenses | $463.61M | $358.41M | $339.77M | $349.07M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $466000.00 | $344000.00 | $339000.00 | $330000.00 |
| EBITDA | -$808000.00 | -$21.14M | -$8.45M | $7.50M |
| EBITDA Ratio | -$0.002 | -$0.06 | -$0.03 | $0.02 |
| Operating Income | -$1.27M | -$21.45M | -$8.79M | $7.19M |
| Operating Income Ratio | -$0.003 | -$0.06 | -$0.03 | $0.02 |
| Other Income/Expenses (Net) | $0.00 | -$33000.00 | $0.00 | -$17000.00 |
| Income Before Tax | -$1.27M | -$21.48M | -$8.79M | $7.17M |
| Income Before Tax Ratio | -$0.003 | -$0.06 | -$0.03 | $0.02 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$1.27M | -$22.09M | -$9.15M | $7.41M |
| Net Income Ratio | -$0.003 | -$0.07 | -$0.03 | $0.02 |
| EPS | -$0.003 | -$0.04 | -$0.02 | $0.01 |
| Diluted EPS | -$0.003 | -$0.04 | -$0.02 | $0.01 |
| Weighted Avg Shares Outstanding | $497.06M | $491.87M | $490.18M | $487.48M |
| Weighted Avg Shares Outstanding (Diluted) | $497.06M | $491.87M | $490.18M | $495.18M |
Over the last four quarters, Clover Health Investments, Corp. achieved steady financial progress, growing revenue from $356.26M in Q2 2024 to $462.33M in Q1 2025. Gross profit stayed firm with margins at 24% in Q1 2025 versus 30% in Q2 2024. Operating income totaled -$1.27M in Q1 2025, maintaining a -0% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$808000.00. Net income rose to -$1.27M, with EPS at -$0.003. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan